Focused Wealth Management, Inc Biogen Inc. Transaction History

Focused Wealth Management, Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$187.54 - $223.02 $1,500 - $1,784	-8 Reduced 7.41%	100 $20,000
Q1 2022 Apr 29, 2022	SELL	$193.77 - $244.14 $104,635 - $131,835	-540 Reduced 83.33%	108 $23,000
Q3 2021 Oct 12, 2021	BUY	$282.99 - $369.05 $2,263 - $2,952	8 Added 1.25%	648 $183,000
Q2 2021 Jul 15, 2021	BUY	$259.0 - $414.71 $3,885 - $6,220	15 Added 2.4%	640 $222,000
Q2 2020 Jul 24, 2020	SELL	$258.66 - $342.55 $51,732 - $68,510	-200 Reduced 24.24%	625 $167,000
Q3 2019 Nov 06, 2019	BUY	$217.44 - $243.88 $27,180 - $30,485	125 Added 17.86%	825 $192,000
Q2 2019 Jul 19, 2019	BUY	$219.29 - $241.72 $131,574 - $145,032	600 Added 600.0%	700 $164,000
Q2 2018 Aug 15, 2018	SELL	$257.52 - $306.91 $96,570 - $115,091	-375 Reduced 78.95%	100 $29,000
Q4 2017 Feb 13, 2018	SELL	$307.64 - $344.58 $115,365 - $129,217	-375 Reduced 44.12%	475 $151,000
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $105,431 - $123,633	375 Added 78.95%	850 $266,000
Q2 2017 Aug 14, 2017	BUY	N/A	475	475 $129,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Focused Wealth Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Focused Wealth Management, Inc with notifications on news.